Camfil, a global leader in clean air solutions, shares its tailored solutions designed specifically to address critical ...

Stacey Rusch is an entrepreneur, philanthropist, and personality. With a career spanning media, she turned to star on Bravo’s ...

Onco360 is grateful for the opportunity to partner with the team at Deciphera and become a specialty pharmacy provider for ROMVIMZA,” said Benito Fernandez, Chief Commercial Officer. “This addition ...

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

A live webcast of the presentation can be accessed through the Investors section of the Company's website at www.lyell.com. Following the live presentation, a replay of the webcast will be available ...

Founded by Stacy L. Carter—a mother, entrepreneur, and non-smoker diagnosed with stage IV lung cancer in 2023—Stage4Hope was born out of her own journey and the urgent need to bring hope, clarity, and ...

Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to ...

Insight Molecular Diagnostics (Nasdaq: IMDX) moved its headquarters from Irvine, Calif., to Nashville, Tenn., in June 2025. The company’s new NASDAQ symbol became effective June 18. Investors may ...